Multidisciplinary management of acromegaly: a consensus
Abstract The 13th Acromegaly Consensus Conference was held in November 2019 in Fort
Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and …
Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and …
[HTML][HTML] A Pituitary Society update to acromegaly management guidelines
M Fleseriu, BMK Biller, PU Freda, MR Gadelha… - Pituitary, 2021 - Springer
Guidelines and consensus statements ensure that physicians managing acromegaly
patients have access to current information on evidence-based treatments to optimize …
patients have access to current information on evidence-based treatments to optimize …
[HTML][HTML] COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
Background COVID-19 has completely changed our daily clinical practice as well as our
social relations. Many organs and biological systems are involved in SARS-Cov-2 infection …
social relations. Many organs and biological systems are involved in SARS-Cov-2 infection …
[HTML][HTML] COVID-19 and the pituitary
S Frara, A Allora, L Castellino, L di Filippo, P Loli… - Pituitary, 2021 - Springer
Background Despite COVID-19 being identified as severe respiratory viral infection,
progressively many relevant endocrine manifestations have been reported greatly …
progressively many relevant endocrine manifestations have been reported greatly …
[HTML][HTML] Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective
M Fleseriu, M Buchfelder, JS Cetas, PK Fazeli… - Pituitary, 2020 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain that has
caused the coronavirus disease 2019 (COVID-19) pandemic, has presented healthcare …
caused the coronavirus disease 2019 (COVID-19) pandemic, has presented healthcare …
Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide
Abstract Purpose The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy
and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously …
and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously …
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
M Fleseriu, D Führer-Sakel… - European journal of …, 2021 - academic.oup.com
Objective To report the final long-term safety and efficacy analyses of patients with
acromegaly treated with pegvisomant from the ACROSTUDY. Design Global (15 countries) …
acromegaly treated with pegvisomant from the ACROSTUDY. Design Global (15 countries) …
High prevalence of vertebral fractures associated with preoperative GH levels in patients with recent diagnosis of acromegaly
Context Osteopathy and morphometric vertebral fractures (VFs) are emerging complications
in acromegaly. However, the prediction of VFs in this clinical setting is still a matter of …
in acromegaly. However, the prediction of VFs in this clinical setting is still a matter of …
Global epidemiology of acromegaly: a systematic review and meta-analysis
S Crisafulli, N Luxi, J Sultana, A Fontana… - European journal of …, 2021 - academic.oup.com
Objective To date, no systematic reviews and meta-analysis on the global epidemiology of
acromegaly are available in the literature. The aims of this study are to provide a systematic …
acromegaly are available in the literature. The aims of this study are to provide a systematic …
Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review
N Agrawal, AG Ioachimescu - Pituitary, 2020 - Springer
Purpose Biochemical control is the main determinant of survival, clinical manifestations and
comorbidities in acromegaly. Transsphenoidal selective adenomectomy (TSA) is the initial …
comorbidities in acromegaly. Transsphenoidal selective adenomectomy (TSA) is the initial …